Our analyses of the RNA expression from the TCGA adenocarcinoma database indicated that patients with higher than median CYTSA expression had poorer survival than patients with lower than median CYTSA expression (Figure 7). The gene discussed is SPECC1L; the disease is adenocarcinoma.